文献速递血管炎其他结缔组织病

超微血管成像评估白塞综合征静脉血管壁

Venous vessel-wall assessment with superb microvascular imaging in Behçet syndrome.
PubMed 文献 · RMD Open · 2025-04-05

研究纳入51例白塞综合征(BS)患者和31例非BS患者,对可触及红色病变行B型超声、彩色多普勒、能量多普勒及超微血管成像(SMI),并按血管壁受累面积百分比对浅表血栓性静脉炎(STM)病变的血管壁信号分级。BS患者STM病变中SMI显示血管壁信号者21/26(81%),非BS仅3/17(18%);BS中16/21(76%)至少为2级信号,非BS仅1/3。结论认为SMI评估BS血管壁可能是有前景的无创、廉价、可靠且无需对比剂的影像方法。

要点

  • BS患者STM病变SMI血管壁信号阳性21/26(81%),非BS仅3/17(18%)。
  • BS中16/21(76%)STM病变SMI信号至少2级,非BS仅1/3。
  • 结节性红斑样病变在BS和非BS中SMI均未见血管壁信号。

核心结论

  • 在BS中应用SMI评估血管壁可能是显示炎症的有前景方法,为廉价、无创、可靠且无需对比剂的影像手段。

研究设计与样本

  • 研究纳入51例BS患者和31例非BS患者,后者体检均有可触及红色病变。
  • 由同一放射科医生完成B型超声、彩色多普勒超声、能量多普勒超声和SMI检查并记录图像,另由一名放射科医生独立评估记录图像。
  • 按受累血管壁面积百分比将STM病变的SMI血管壁信号强度分为四级:0级无信号、1级<25%、2级25%-50%、3级50%-75%、4级>75%。

主要发现

  • 经彩色多普勒超声诊断,26例BS和17例非BS患者的病变为STM。
  • STM病变SMI显示血管壁信号者:BS 21/26(81%),非BS 3/17(18%)。
  • SMI信号至少2级者:BS 16/21(76%),非BS 1/3。
  • 经彩色多普勒超声诊断,25例BS和11例非BS患者的病变为结节性红斑,SMI在这些患者中均未见血管壁信号。

关键数值与推荐

  • SMI血管壁信号分级按受累血管壁面积百分比:0级无信号、1级<25%、2级25%-50%、3级50%-75%、4级>75%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Superb microvascular imaging (SMI) provides a more sensitive assessment of small vessels compared with power and colour Doppler ultrasonography (PDUS and CDUS). We aimed to investigate the potential of SMI for use in research and clinical practice in Behçet syndrome (BS) and to gain a better understanding of erythema nodosum (EN) like and superficial thrombophlebitis (STM) lesions using SMI. METHODS: We studied 51 patients with BS and 31 patients with non-BS with red palpable lesions on physical examination. B-mode US, CDUS, PDUS and SMI were performed and recorded by the same radiologist and recorded images were additionally evaluated independently by another radiologist. Vessel-wall signal intensity of STM lesions by SMI was graded in four groups according to the percentages of the affected vessel-wall area (Grade 0: no signal, Grade 1: < 25%, Grade 2: 25%-50%, Grade 3: 50%-75% and Grade 4: >75%). RESULTS: The lesions of 26 patients with BS and 17 patients with non-BS were diagnosed as STM with CDUS. SMI of STM lesions revealed vessel-wall signals in 21/26 patients with BS (81%), in contrast to only 3/17 (18%) patients with non-BS. While 16 of 21 patients with BS (76%) had at least grade 2 signal, only 1 of 3 non-BS had it. Lesions of 25 BS and 11 non-BS were diagnosed as EN by CDUS and SMI showed no vessel-wall signal in these patients. CONCLUSIONS: Evaluation of the vessel wall with SMI in BS may be a promising approach for showing inflammation as an inexpensive, non-invasive and reliable imaging method that does not require a contrast agent.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Kayadibi Y, Ozguler Y, Melikoglu M, et al. Venous vessel-wall assessment with superb microvascular imaging in Behçet syndrome. RMD Open. 2025. PMID: 40187771. doi:10.1136/rmdopen-2024-005382

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。